Evonik stock: Parmantier sets EUR 20.50 target for Evonik stock

Published on 10/19/2026 at 15:45 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Evonik reports on November 3, 2026. Evonik stock costs EUR 21.27 on October 19, 2026 at 3:34 p.m. CEST, minus 0.70 percent versus the Xetra close.

Analyst target and results date

Parmantier & Cie. set a EUR 20.50 target for Evonik on October 6, 2026.
Evonik is scheduled to report third-quarter results on November 3, 2026.
Evonik stock costs EUR 21.27 at Lang & Schwarz on October 19, 2026 at 3:34 p.m. CEST, minus 0.70 percent versus the Xetra close of October 16, 2026.
Evonik's price-to-earnings ratio was 82.13 as of October 19, 2026.

Extreme Makrofotografie transparenter Silikagelkugeln und Polymerpartikel auf schwarzem Hintergrund — Evonik Industries DE000EVNK013 zeigt eine extreme Makroaufnahme transluzenter Spezialsilika-Kugeln auf dunklem Hintergrund, Illustration mit AI erstellt.

Parmantier & Cie. set a EUR 20.50 target for Evonik on October 6, 2026, according to EQS News. The price stands 3.76 percent above that target. At Lang & Schwarz, Evonik stock was trading at EUR 21.27 on October 19, 2026 at 3:34 p.m. CEST, minus 0.70 percent versus the Xetra close of October 16, 2026 (EUR 21.42).

November 3 results date

Evonik's next scheduled reporting date is November 3, 2026. The company's investor-relations calendar identifies that date for its third-quarter 2026 report, according to Evonik. That appointment gives the stock a defined near-term event beyond the current analyst target.

Stock position and range

The October 19 quote was 2.61 percent below Evonik's 52-week high of EUR 21.84 and 70.29 percent above its 52-week low of EUR 12.49. The range and market value were reported for October 19, 2026. The bid was EUR 21.26 and the ask EUR 21.28 at 3:34 p.m. CEST, keeping the spread at EUR 0.02.

Trading volume for Evonik was 63,741 shares as of 3:25 p.m. CEST, against an average volume of 1,319,726 shares. The price therefore sat near the upper end of its annual range while turnover was below the stated average.

Valuation and market comparison

Evonik had a market capitalization of EUR 9.9 billion and a price-to-earnings ratio of 82.13 as of October 19, 2026. Its trailing dividend yield was 0.05 percent. These market measures place the company in a materially different valuation position from larger and more heavily traded German chemical peers.

Comparison with peers

Evonik: minus 0.70 percent, P/E 82.13, market capitalization EUR 9.9 billion

BASF (Xetra, EUR): minus 1.73 percent, P/E 7.86, market capitalization EUR 45.1 billion

Lanxess (Xetra, EUR): minus 4.57 percent, P/E minus 1.64, market capitalization EUR 1.1 billion

Price remains near annual high

Evonik's EUR 21.27 quote was EUR 0.57 below the 52-week high and EUR 8.78 above the low. The October 19 move was modest against the Xetra close, while the scheduled November report provides the next dated corporate checkpoint.

The further course of trading is shown by the continuously updated real-time quote of Evonik stock.